Cargando…
In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization
Treating pain by inhibiting ATP activation of P2X3-containing receptors heralds an exciting new approach to pain management, and Afferent's program marks the vanguard in a new class of drugs poised to explore this approach to meet the significant unmet needs in pain management. P2X3 receptor su...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265711/ https://www.ncbi.nlm.nih.gov/pubmed/22095157 http://dx.doi.org/10.1007/s11302-011-9271-6 |